Advisor Group Holdings, Inc. Checkpoint Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.02 - $10.6 $49,902 - $518,594	48,924 Added 25.35%	241,940 $252,000
Q2 2022 Aug 10, 2022	BUY	$0.97 - $1.77 $18,850 - $34,398	19,434 Added 11.2%	193,016 $199,000
Q1 2022 May 04, 2022	BUY	$1.53 - $3.25 $166,034 - $352,686	108,519 Added 166.79%	173,582 $307,000
Q3 2021 Nov 05, 2021	BUY	$2.5 - $3.53 $134,365 - $189,723	53,746 Added 474.91%	65,063 $215,000
Q2 2021 Aug 02, 2021	SELL	$2.36 - $3.2 $2,666 - $3,616	-1,130 Reduced 9.08%	11,317 $33,000
Q1 2021 May 13, 2021	BUY	$2.6 - $4.16 $7,321 - $11,714	2,816 Added 29.24%	12,447 $39,000
Q4 2020 Feb 10, 2021	BUY	$2.19 - $2.96 $1,215 - $1,642	555 Added 6.12%	9,631 $25,000
Q3 2020 Nov 12, 2020	BUY	$1.62 - $4.24 $2,391 - $6,258	1,476 Added 19.42%	9,076 $24,000
Q1 2020 May 18, 2020	BUY	$1.11 - $2.43 $8,436 - $18,468	7,600 New	7,600 $11,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $351M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.